rs35062843

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_012452.3(TNFRSF13B):​c.291T>G​(p.Pro97Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0412 in 1,614,174 control chromosomes in the GnomAD database, including 1,679 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 125 hom., cov: 32)
Exomes 𝑓: 0.042 ( 1554 hom. )

Consequence

TNFRSF13B
NM_012452.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.313

Publications

10 publications found
Variant links:
Genes affected
TNFRSF13B (HGNC:18153): (TNF receptor superfamily member 13B) The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
TNFRSF13B Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, G2P, Ambry Genetics
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-16948892-A-C is Benign according to our data. Variant chr17-16948892-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.313 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0965 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFRSF13BNM_012452.3 linkc.291T>G p.Pro97Pro synonymous_variant Exon 3 of 5 ENST00000261652.7 NP_036584.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFRSF13BENST00000261652.7 linkc.291T>G p.Pro97Pro synonymous_variant Exon 3 of 5 1 NM_012452.3 ENSP00000261652.2

Frequencies

GnomAD3 genomes
AF:
0.0365
AC:
5561
AN:
152176
Hom.:
121
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.0551
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.00943
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.0331
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0383
Gnomad OTH
AF:
0.0483
GnomAD2 exomes
AF:
0.0415
AC:
10448
AN:
251480
AF XY:
0.0443
show subpopulations
Gnomad AFR exome
AF:
0.0239
Gnomad AMR exome
AF:
0.0383
Gnomad ASJ exome
AF:
0.0115
Gnomad EAS exome
AF:
0.00799
Gnomad FIN exome
AF:
0.0375
Gnomad NFE exome
AF:
0.0373
Gnomad OTH exome
AF:
0.0401
GnomAD4 exome
AF:
0.0417
AC:
61000
AN:
1461880
Hom.:
1554
Cov.:
36
AF XY:
0.0434
AC XY:
31551
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.0251
AC:
839
AN:
33480
American (AMR)
AF:
0.0411
AC:
1837
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
288
AN:
26136
East Asian (EAS)
AF:
0.00851
AC:
338
AN:
39700
South Asian (SAS)
AF:
0.100
AC:
8652
AN:
86256
European-Finnish (FIN)
AF:
0.0385
AC:
2055
AN:
53418
Middle Eastern (MID)
AF:
0.0335
AC:
193
AN:
5768
European-Non Finnish (NFE)
AF:
0.0398
AC:
44275
AN:
1112002
Other (OTH)
AF:
0.0418
AC:
2523
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3710
7421
11131
14842
18552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1732
3464
5196
6928
8660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0366
AC:
5572
AN:
152294
Hom.:
125
Cov.:
32
AF XY:
0.0375
AC XY:
2795
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0245
AC:
1019
AN:
41572
American (AMR)
AF:
0.0551
AC:
842
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3472
East Asian (EAS)
AF:
0.00946
AC:
49
AN:
5182
South Asian (SAS)
AF:
0.104
AC:
501
AN:
4818
European-Finnish (FIN)
AF:
0.0331
AC:
351
AN:
10610
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0383
AC:
2605
AN:
68032
Other (OTH)
AF:
0.0544
AC:
115
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
279
558
838
1117
1396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0349
Hom.:
54
Bravo
AF:
0.0342
Asia WGS
AF:
0.0990
AC:
344
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency, common variable, 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Common Variable Immune Deficiency, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
9.0
DANN
Benign
0.56
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35062843; hg19: chr17-16852206; API